Zobrazeno 1 - 10
of 14
pro vyhledávání: '"van Werkhoven ED"'
Autor:
van Loevezijn AA; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Surgical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Geluk CS; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Plastic and Reconstructive Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van den Berg MJ; Department of Plastic and Reconstructive Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Vrancken Peeters MTFD; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Surgical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., van Duijnhoven FH; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Hoornweg MJ; Department of Plastic and Reconstructive Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. m.hoornweg@nki.nl.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Apr; Vol. 198 (2), pp. 295-307. Date of Electronic Publication: 2023 Jan 24.
Autor:
van Loevezijn AA; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Surgery, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., van der Noordaa MEM; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Stokkel MPM; Department of Nuclear Medicine, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Groen EJ; Department of Pathology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Loo CE; Department of Radiology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Elkhuizen PHM; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Russell NS; Department of Radiation Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., van Duijnhoven FH; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands., Vrancken Peeters MTFD; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Amsterdam, The Netherlands. m.vrancken@nki.nl.; Department of Surgery, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. m.vrancken@nki.nl.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2022 May; Vol. 193 (1), pp. 37-48. Date of Electronic Publication: 2022 Mar 03.
Autor:
Visser C; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Swinkels M; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Werkhoven ED; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Croles FN; Department of Internal Medicine, Hospital St. Jansdal, Harderwijk, The Netherlands., Noordzij-Nooteboom HS; Department of Internal Medicine, van Weel-Bethesda Hospital, Dirksland, The Netherlands., Eefting M; Department of Internal Medicine, Beatrix Hospital, Gorinchem, The Netherlands., Last-Koopmans SM; Department of Internal Medicine, Beatrix Hospital, Gorinchem, The Netherlands., Idink C; Department of Internal Medicine, ZorgSaam Hospital, Terneuzen, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Santbergen B; Department of Internal Medicine, IJsselland Hospital, Capelle aan den IJssel, The Netherlands., Jobse PA; Department of Internal Medicine, ADRZ Hospital, Goes, The Netherlands; and., Baboe F; Department of Internal Medicine, Bravis Hospital, Roosendaal, The Netherlands., Te Boekhorst PAW; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Leebeek FWG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Kruip MJHA; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jansen AJG; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2022 Mar 22; Vol. 6 (6), pp. 1637-1644.
Autor:
van Loevezijn AA; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Surgery, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands., Stokkel MPM; Department of Nuclear Medicine, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van der Noordaa MEM; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Duijnhoven FH; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Vrancken Peeters MTFD; Department of Surgical Oncology, Netherlands Cancer Institute - Antoni Van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. m.vrancken@nki.nl.; Department of Surgery, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. m.vrancken@nki.nl.
Publikováno v:
EJNMMI research [EJNMMI Res] 2021 Aug 21; Vol. 11 (1), pp. 78. Date of Electronic Publication: 2021 Aug 21.
Autor:
van der Voort A; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., van Ramshorst MS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands., van Werkhoven ED; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Mandjes IA; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Kemper I; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Vulink AJ; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, the Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Zwolle, the Netherlands., Tick LW; Department of Medical Oncology, Maxima Medical Center, Eindhoven, the Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo, the Netherlands., Mandigers CM; Department of Medical Oncology, Canisius Wilhelmina hospital, Nijmegen, the Netherlands., van Warmerdam LJ; Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, the Netherlands., Wesseling J; Department of Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Vrancken Peeters MT; Department of Surgery, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn SC; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2021 Jul 01; Vol. 7 (7), pp. 978-984.
Autor:
van Loevezijn AA; Departments of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., van der Noordaa MEM; Departments of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., van Werkhoven ED; Biometrics, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Loo CE; Radiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Winter-Warnars GAO; Radiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Wiersma T; Radiation Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van de Vijver KK; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Groen EJ; Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Blanken-Peeters CFJM; Department of Surgical Oncology, Rijnstate Hospital, Arnhem, The Netherlands., Zonneveld BJGL; Department of Radiology, Deventer hospital, Deventer, The Netherlands., Sonke GS; Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Duijnhoven FH; Departments of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands., Vrancken Peeters MTFD; Departments of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. m.vrancken@nki.nl.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2021 Jun; Vol. 28 (6), pp. 3243-3253. Date of Electronic Publication: 2020 Dec 02.
Autor:
van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van der Voort A; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Mandjes IA; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Kemper I; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Dezentjé VO; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands., Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands., Honkoop AH; Department of Medical Oncology, Isala, Zwolle, Netherlands., Tick LW; Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands., van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands., Mandigers CM; Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands., van Warmerdam LJ; Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands., Wesseling J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Vrancken Peeters MT; Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Utrecht, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: g.sonke@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 Dec; Vol. 19 (12), pp. 1630-1640. Date of Electronic Publication: 2018 Nov 06.
Autor:
Boekhout AH; Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Gietema JA; Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Milojkovic Kerklaan B; Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven ED; Biometrics Department, Netherlands Cancer Institute, Amsterdam, the Netherlands., Altena R; Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Honkoop A; Department of Internal Medicine, Isala Clinics, Zwolle, the Netherlands., Los M; Department of Internal Medicine, Antonius Hospital, Nieuwegein, the Netherlands., Smit WM; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands., Nieboer P; Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands., Smorenburg CH; Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands., Mandigers CM; Department of Internal Medicine, Canisius Wilhemina Hospital, Nijmegen, the Netherlands., van der Wouw AJ; Department of Internal Medicine, VieCuri Medical Center Noord-Limburg, Venlo, the Netherlands., Kessels L; Department of Internal Medicine, Deventer Hospital, Deventer, the Netherlands., van der Velden AW; Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands., Ottevanger PB; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Smilde T; Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, the Netherlands., de Boer J; Department of Internal Medicine, Hospital de Tjongerschans, Heerenveen, the Netherlands., van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, the Netherlands., Kema IP; Department of Laboratory Medicine University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EG; Department of Medical Oncology University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schellens JH; Division of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands18Department of Pharmaceutical Sciences, Science Faculty Utrecht University, Utrecht, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2016 Aug 01; Vol. 2 (8), pp. 1030-7.
Autor:
van Harten MC; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: m.v.harten@nki.nl., Hoebers FJ; Department of Radiation Oncology (MAASTRO), Research Institute GROW, Maastricht University, Maastricht, The Netherlands., Kross KW; Department of Otorhinolaryngology and Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Brekel MW; Department of Head and Neck Surgery and Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, The Netherlands; Department of Phonetic Sciences, University of Amsterdam, The Netherlands., van Dijk BA; Department of Research, Comprehensive Cancer Centre The Netherlands (IKNL), Utrecht, The Netherlands; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Publikováno v:
Oral oncology [Oral Oncol] 2015 Mar; Vol. 51 (3), pp. 272-8. Date of Electronic Publication: 2014 Dec 22.
Autor:
Wilbers J; Department of Neurology, Radboud University Nijmegen Medical Center, The Netherlands. Electronic address: Joyce.Wilbers@radboudumc.nl., Dorresteijn LD; Department of Neurology, Medisch Spectrum Twente, Enschede, The Netherlands. Electronic address: L.Dorresteijn@mst.nl., Haast R; Department of Neurology, Radboud University Nijmegen Medical Center, The Netherlands. Electronic address: roy.haast@maastrichtuniversity.nl., Hoebers FJ; Maastricht University Medical Center, Department of Radiation Oncology (MAASTRO clinic), The Netherlands. Electronic address: frank.hoebers@maastro.nl., Kaanders JH; Department of Radiation Oncology, University Nijmegen Medical Center, The Netherlands. Electronic address: j.kaanders@radboudumc.nl., Boogerd W; Department of Neurology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: w.boogerd@nki.nl., van Werkhoven ED; Department of Biometrics, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: e.v.werkhoven@nki.nl., Nowee ME; Department of Radiotherapy, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: m.nowee@nki.nl., Hansen HH; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Rik.Hansen@radboudumc.nl., de Korte CL; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Chris.deKorte@radboudumc.nl., Kappelle AC; Department of Neurology, Radboud University Nijmegen Medical Center, The Netherlands. Electronic address: Arnoud.Kappelle@radboudumc.nl., van Dijk EJ; Department of Neurology, Radboud University Nijmegen Medical Center, The Netherlands. Electronic address: Ewoud.vanDijk@radboudumc.nl.
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2014 Dec; Vol. 113 (3), pp. 359-63. Date of Electronic Publication: 2014 Nov 14.